Brief: Kane Biotech Announces Second Quarter 2022 Financial Results
25/08/2022 21:19
Aug 25 (Reuters) - Kane Biotech Inc KNE.V :
* KANE BIOTECH ANNOUNCES SECOND QUARTER 2022 FINANCIAL
RESULTS
* KANE BIOTECH INC - QTRLY LOSS PER SHARE OF $0.01
* KANE BIOTECH INC Q2 REVENUE ROSE 201 PERCENT TO C$839,579
Source text for Eikon: ID:nGNX4svyJr
Further company coverage: KNE.V
Recent news on Kane Biotech
See all newsBrief: Kane Biotech Announces FDA 510(K) Clearance For Revyve® Antimicrobial Skin And Wound Cleanser
Brief: Kane Biotech Restarts Commercial Activities And Strengthens North American Management
Brief: Kane Biotech Completes U.S. FDA 510(K) Submission For Revyve Antimicrobial Wound Cleanser
Brief: Kane Biotech Announces Second Quarter 2025 Financial Results
Brief: Kane Biotech provides further corporate update